These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 681749)
1. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene. Ruco LP; Meltzer MS; Rosenstreich DL J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749 [No Abstract] [Full Text] [Related]
2. Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. Boraschi D; Meltzer MS J Immunol; 1980 Mar; 124(3):1050-3. PubMed ID: 6987306 [No Abstract] [Full Text] [Related]
3. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. Fogler WE; Talmadge JE; Fidler IJ J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360 [TBL] [Abstract][Full Text] [Related]
4. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. Boraschi D; Meltzer MS J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721 [No Abstract] [Full Text] [Related]
5. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. Ruco LP; Meltzer MS J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076 [No Abstract] [Full Text] [Related]
6. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus. Tagliabue A; Boraschi D; McCoy JL J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137 [No Abstract] [Full Text] [Related]
7. Induction of macrophage-mediated tumor cytotoxicity by a hamster monoclonal antibody with specificity for lipopolysaccharide receptor. Chen TY; Bright SW; Pace JL; Russell SW; Morrison DC J Immunol; 1990 Jul; 145(1):8-12. PubMed ID: 1694209 [TBL] [Abstract][Full Text] [Related]
8. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. Ruco LP; Meltzer MS J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578 [No Abstract] [Full Text] [Related]
9. Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte. Vallera DA; Gamble CE; Schmidtke JR J Immunol; 1980 Feb; 124(2):641-9. PubMed ID: 6444315 [No Abstract] [Full Text] [Related]
10. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562 [TBL] [Abstract][Full Text] [Related]
11. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
12. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. Meltzer MS; Stevenson MM J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142 [No Abstract] [Full Text] [Related]
13. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore. Akagawa KS; Kamoshita K; Onodera S; Tokunaga T Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284 [TBL] [Abstract][Full Text] [Related]
14. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. Hogan MM; Vogel SN J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760 [TBL] [Abstract][Full Text] [Related]
15. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS. Taramelli D; Varesio L J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132 [TBL] [Abstract][Full Text] [Related]
16. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma. Flebbe LM; Chapes SK; Morrison DC J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032 [TBL] [Abstract][Full Text] [Related]
17. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function. Hamilton TA; Jansen MM; Somers SD; Adams DO J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. Paulnock DM; Lambert LE J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906 [TBL] [Abstract][Full Text] [Related]